Healthcentral.Com Announces Commencement Of Trading On Nasdaq National Market
EMERYVILLE, CALIFORNIA - December 7, 1999 - HealthCentral.com (Nasdaq: HCEN), an online provider of healthcare content and e-commerce, today announced its initial public offering of 7.5 million shares of common stock at a price of $11.00 per share. The shares will commence trading today on the Nasdaq National Market under the symbol HCEN.
The offering was jointly led by Lehman Brothers Inc. and Hambrecht & Quist LLC. The other co-managing underwriters include Pacific Growth Equities, Inc., Wit Capital Corporation and Fidelity Capital Markets. The company has granted the underwriters the option to purchase up to 1,125,000 additional shares to cover over-allotments, if any. The underwriters may exercise this option within 30 days following the effective date of the offering.
A copy of the prospectus relating to this offering may be obtained from Lehman Brothers Inc., Three World Financial Center, New York, NY 10285.
HealthCentral.com, co-founded by Dr. Dean Edell, provides online healthcare content and e-commerce to consumers through the HealthCentral.com network. This network of information services provides consumers with highly personalized interactive tools, including custom newsletters, personalized health information pages and personalized risk assessments. HealthCentral.com also operates an online drug store, HealthCentralRx.com with over 23,000 SKUs of health-related products provided by its fulfillment partner, Bergen Brunswig. HealthCentral.com also acts as an application service provider by designing, hosting and maintaining private label websites for healthcare institutions.
C. Fred Toney SVP and Chief Financial Officer
Belinda Brouder-Hayes Noonan/Russo Communications Phone: 212.696.4455 ext. 224 firstname.lastname@example.org
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state of jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under securities laws of any such state or jurisdiction.
Except for the historical information contained herein, the matters discussed in this news release are forward-looking statements involving risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. Potential risks and uncertainties include, but are not limited to, HealthCentral.com's limited operating history, HealthCentral.com's need to generate revenues, the substantial competition HealthCentral.com faces, HealthCentral.com's substantial payment obligations, the risks inherent in operating an online pharmacy, possible liability related to content on or accessed through HealthCentral.com's websites, HealthCentral.com's need to build its brand names quickly, HealthCentral.com's dependence on Dr. Edell, HealthCentral.com's possible need to raise additional funds post-IPO, the effect of substantial and changing government regulation, possible systems interruptions, a failure to integrate HealthCentral.com's recent acquisitions or manage HealthCentral.com's growth, a failure to attract and retain key employees and risks related to intellectual property. Further information regarding these and other risks is included in HealthCentral.com's S-1 registration.